These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26344223)

  • 21. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
    Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
    Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formation and persistence of sterigmatocystin--DNA adducts in rat liver determined via 32P-postlabeling analysis.
    Reddy MV; Irvin TR; Randerath K
    Mutat Res; 1985 Oct; 152(1):85-96. PubMed ID: 4047087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ³²P-postlabeling analysis of DNA adducts.
    Schmeiser HH; Stiborova M; Arlt VM
    Methods Mol Biol; 2013; 1044():389-401. PubMed ID: 23896889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,N6-ethenodeoxyadenosine and 3,N4-ethenodeoxycytine in liver DNA from humans and untreated rodents detected by immunoaffinity/32P-postlabeling.
    Nair J; Barbin A; Guichard Y; Bartsch H
    Carcinogenesis; 1995 Mar; 16(3):613-7. PubMed ID: 7697821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of benzylic adducts in DNA and nucleotides from 7-sulfooxymethyl-12-methylbenz[a]anthracene and related compounds by 32P-postlabeling using new TLC systems.
    Vadhanam MV; Horn J; Flesher JW; Gupta RC
    Chem Biol Interact; 2003 Jul; 146(1):81-7. PubMed ID: 12902155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
    Randerath K; Randerath E
    J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
    Gorelick NJ; Wogan GN
    Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
    Reddy MV; Randerath K
    Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
    Hatcher JF; Swaminathan S
    Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of DNA adducts using a quantitative long PCR technique and the fluorogenic 5' nuclease assay (TaqMan).
    Laws GM; Skopek TR; Reddy MV; Storer RD; Glaab WE
    Mutat Res; 2001 Dec; 484(1-2):3-18. PubMed ID: 11733068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 32P-postlabeling of DNA adducts arising from complex mixtures: HPLC versus TLC separation applied to adducts from petroleum products.
    Eriksson HL; Zeisig M; Ekström LG; Möller L
    Arch Toxicol; 2004 Mar; 78(3):174-81. PubMed ID: 14652713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
    Reddy MV; Randerath K
    Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-resolution TLC mapping and characterization of 32P-postlabeled monophosphate 7,12-dimethylbenz[a]anthracene-DNA adducts.
    Yang PF; Randerath K
    Carcinogenesis; 1990 Jan; 11(1):159-64. PubMed ID: 2104782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 32P-postlabeling analysis of adducts formed from 1-phenylazo-2-hydroxynaphthalene (Sudan I, Solvent Yellow 14) with DNA and homopolydeoxyribonucleotides.
    Stiborová M; Frei E; Schmeiser HH; Wiessler M
    Carcinogenesis; 1992 Jul; 13(7):1221-5. PubMed ID: 1638690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of 32P-postlabeling and HPLC-FD analysis of DNA adducts in rats acutely exposed to benzo(a)pyrene.
    Godschalk RW; Vermeer IT; Kriek E; Floot B; Schilderman PA; Moonen EJ; Kleinjans JC; van Schooten FJ
    Chem Biol Interact; 1997 Apr; 104(1):41-54. PubMed ID: 9158694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ³²P-postlabeling analysis of DNA adducts.
    Phillips DH; Arlt VM
    Methods Mol Biol; 2014; 1105():127-38. PubMed ID: 24623224
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of tamoxifen-induced DNA adducts by 32P-postlabelling assay using different chromatographic techniques.
    Koskinen M; Rajaniemi H; Hemminki K
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 691(1):155-60. PubMed ID: 9140769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 32P-postlabeling assay for carcinogen-DNA adducts: description of beta shielding apparatus and semi-automatic spotting and washing devices that facilitate the handling of multiple samples.
    Reddy MV; Blackburn GR
    Carcinogenesis; 1990 Apr; 11(4):683-7. PubMed ID: 2323007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accurate and sensitive quantitation of N7-methyldeoxyguanosine-3'-monophosphate by 32P-postlabeling and storage-phosphor imaging.
    Haque K; Cooper DP; van Delft JH; Lee SM; Povey AC
    Chem Res Toxicol; 1997 Jun; 10(6):660-6. PubMed ID: 9208172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods.
    Reddy MV
    J Chromatogr; 1993 May; 614(2):245-51. PubMed ID: 8314936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.